With a global presence in a market with high entry barriers, Sanstar Limited has a large and diversified customer base.

The IPO of Sanstar Limited opens for bid on 19th July. The IPO consists of a fresh issue and an offer for sale.

Regarding personal finance and investments, mutual funds, especially equity funds, always have an interesting discussion. The equity market is on a bull run, with the Sensex and Nifty touching new highs

Embark on the historical journey of gold and explore its potential as a valuable asset. Let's analyse the dynamic price movements and future prospects of this valuable asset.

Mutual funds are subject to market risks, read all scheme-related documents carefully” is a standard disclaimer for any mutual fund. However, have you wondered what these scheme-related documents are and why it is essential for you to read them? Let us find out.

Monopoly stocks in India show strong market dominance and pricing power, offering potential high returns but posing challenges for investors.

An initial public offering (IPO) is a historic occasion for any company. IPO subscription status and data are among several crucial aspects of the post-IPO launch that companies and investors keenly watch. What's an IPO subscription status, and what are its various aspects? Let's find out.

Emcure Pharmaceuticals Ltd, one of India’s foremost pharma companies, is coming up with its IPO on 3rd June. The IPO consists of a fresh issue and an offer for sale.

The QIB and retail investors’ quotas for Emcure IPO are 50% and 35%, respectively. The company has earmarked several ambitious strategies as part of its expansion plan.

Emcure Pharmaceuticals Ltd boasts a diversified product portfolio and a track record of building brands.